Short answer
Ingevity Corp (NGVT) filed its Q3 2025 10-Q quarterly report on Nov 6, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $263M (down 30.1% year over year) with net income of $44M.
Q3 2025 key financials · XBRL
- Revenue
- $263M
- −30.1% YoY · −27.9% QoQ
- Net income
- $44M
- +140.6% YoY · +129.7% QoQ
- Gross margin
- 46.5%
- EPS (diluted)
- $1.19
- +140.3% YoY · +129.6% QoQ
Source: XBRL data from the Ingevity Corp (NGVT) Q3 2025 10-Q on SEC EDGAR. USD.
Ingevity Corp Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- Newly added trade policy risk from new U.S. tariffs and Chinese retaliatory measures lowering margins on products sold into China
- Materially updated operational risk of facility disruptions, including labor strikes with recent CBA expirations and renewals through mid-2025
- Regulatory/legal risk from tariffs causing increased costs and possible decreased demand, adversely affecting financial results
- Near-term operational risk from dependency on single-site production for key products like extruded honeycomb at Covington, VA plant
- Financial risk from uninsured losses due to disruptions and limited alternative manufacturing capacity increasing potential cost exposure
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Ingevity Corp quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.